Can we now define breakpoints for intracellular bacteria ?
Thanks to those who did the work (or other pertinent works over the past years as well):
Christine Renard (beta-lactams)
Marie-Béatrice Carlier (macrolides, fluoroquinolones)
Andrée Zenebergh (lincosaminides, macrolides)
Bernard Scorneaux (Listeria, interferon)
Yousef Ouadrhiri (Listeria, interferon, IL6)
Sandrine Burton (beta-lactams, efflux mechanisms)
Isabelle Paternotte (beta-lactams, efflux mechanisms)